Karya
Judul/Title The 2022 Indonesia Integrated Management of Childhood Illness (IMCI): Advantages of the Chart Booklet updates during the COVID-19 pandemic
Penulis/Author Dr. dr. Ida Safitri Laksanawati, Sp.A(K) (1) ; Asal Wahyuni Erlin Mulyadi (2); Prof. dr. Eggi Arguni, M.Sc., Ph.D., Sp.A(K). (3); Dr. Fitri Haryanti, S.Kp., M.Kes. (4); SUCI ARDINI W (5); NURULITA AINUN ALMA (6); dr. Nisa Rastiwi (7)
Tanggal/Date 16 2023
Kata Kunci/Keyword
Abstrak/Abstract Indonesia Ministry of Health conduct the revision of the IMCI Chart Booklet according to the latest guidelines, evidence, and epidemiological profile at national and global levels. The combination of virtual and direct meetings could ensure the safety of the desk review since it could minimize inperson contacts; moreover, it brings benefits to the revision process, such as less expensive, time-efficient, more recent, and comprehensive. CONCLUSION The COVID-19 pandemic compelled the 2022 Indonesia IMCI revision team to conduct the desk review of the IMCI Chart Booklet through a combination of online and offline methods. There were benefits in several aspects, and this revision process was less costly, time-efficient, more updated, and comprehensive. Therefore, online meetings only or a combination of virtual and direct meetings (hybrid) could be a strategy to update guidelines in the future, not only during the COVID-19 pandemic.
Bahasa Asli/Original Language English
Level Internasional
Status
Dokumen Karya
No Judul Tipe Dokumen Aksi